EPIENDO PHARMACEUTICALS
EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of a number of major diseases. Epithelial cells are a key component of the barrier that makes up human skin and lung tissue, as well as the intestinal tract and genitalia. Compromised integrity of this barrier is implicated in the progression and non-resolution of inflam... mation. EpiEndo is developing a proprietary portfolio of orally available macrolide drug candidates with promise as first-in-class disease-modifying therapeutics, to address the huge global burden of chronic respiratory diseases and other significant unmet medical needs. EpiEndo’s lead drug candidate, EP395, aims to be the first on-market oral, disease modifying, non-antibiotic, barrier strengthening and anti-inflammatory macrolide for COPD and other inflammatory airway diseases.
EPIENDO PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
ReykjavÃk, Gullbringusysla, Iceland
Country:
Iceland
Website Url:
http://www.epiendo.com
Total Employee:
1+
Status:
Active
Contact:
00 354 454 0090
Email Addresses:
[email protected]
Total Funding:
33.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Organization Schema Microsoft Azure DNS
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Current Advisors List
Current Employees Featured
Founder
Investors List
Kvika Asset Management
Kvika Asset Management investment in Series A - EpiEndo Pharmaceuticals
ABC Ventures
ABC Ventures investment in Series A - EpiEndo Pharmaceuticals
Flerie Invest
Flerie Invest investment in Series A - EpiEndo Pharmaceuticals
European Innovation Council
European Innovation Council investment in Series A - EpiEndo Pharmaceuticals
European Innovation Council
European Innovation Council investment in Debt Financing - EpiEndo Pharmaceuticals
ABC Ventures
ABC Ventures investment in Seed Round - EpiEndo Pharmaceuticals
Icelandic Startups
Icelandic Startups investment in Seed Round - EpiEndo Pharmaceuticals
European Innovation Council
European Innovation Council investment in Grant - EpiEndo Pharmaceuticals
Brunnur Ventures
Brunnur Ventures investment in Angel Round - EpiEndo Pharmaceuticals
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - EpiEndo Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-24 | EpiEndo Pharmaceuticals Expands its Leadership Team, Appointing Stefan Petursson as Chief Financial Officer to Support Future Growth |
Official Site Inspections
http://www.epiendo.com Semrush global rank: 9.42 M Semrush visits lastest month: 160
- Host name: pisi.stefna.is
- IP address: 52.49.138.181
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "EpiEndo Pharmaceuticals"
Investors | EpiEndo Pharmaceuticals
Welcome to EpiEndo Pharmaceuticals’ Investor Page. We are a clinical-stage biopharmaceutical company focused on developing innovative therapies for chronic inflammatory diseases caused by epithelial dysfunction. Based on …See details»
EpiEndo Pharmaceuticals - Crunchbase Company Profile & Funding
Legal Name EpiEndo Pharmaceuticals ehf. Company Type For Profit. Contact Email [email protected]. Phone Number 00 354 454 0090. EpiEndo is a clinical-stage …See details»
EpiEndo Pharmaceuticals - LinkedIn
EpiEndo Pharmaceuticals is an Icelandic clinical stage pharmaceutical company with a unique focus on impairment of epithelial barriers as a common mechanism of many inflammatory conditions such as ...See details»
EpiEndo - NAVA
EpiEndo is a clinical stage pharmaceutical company developing a proprietary portfolio of therapies to address the huge global burden of chronic respiratory diseases. With more than a decade of research into COPD, the team behind …See details»
EpiEndo Pharmaceuticals - Funding, Financials, Valuation & Investors
EpiEndo Pharmaceuticals is a clinical biopharmaceutical company focused on novel solutions for chronic airway diseases. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
EpiEndo Pharmaceuticals - Products, Competitors, Financials, …
EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing treatments for chronic inflammatory diseases, particularly those affecting epithelial barriers. …See details»
EpiEndo Pharmaceuticals ehf - Drug pipelines, Patents ... - Patsnap
Explore EpiEndo Pharmaceuticals ehf with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 6 news, and 6 literature, Technology Platform:Small molecule drug, …See details»
EpiEndo Pharmaceuticals - Craft
EpiEndo Pharmaceuticals has 5 employees at their 1 location and $6.5 m in total funding,. See insights on EpiEndo Pharmaceuticals including office locations, competitors, revenue, …See details»
EpiEndo Pharmaceuticals - Contacts, Employees, Board Members, …
EpiEndo Pharmaceuticals has 4 current employee profiles, including Founder and CIO Fridrik Runar Gardarsson. EpiEndo Pharmaceuticals has 2 board members and advisors, including …See details»
EpiEndo Pharmaceuticals
EpiEndo Pharmaceuticals is founded on the hypothesis that acute exacerbations of chronic airway diseases (CADs) are primarily triggered by insults to the epithelial barrier of the airways. As a …See details»
EpiEndo Pharmaceuticals : Secures EUR 20 Million Series A …
Aug 18, 2021 EpiEndo Pharmaceuticals (www.epiendo.com), a privately held biopharmaceutical company focused on a novel barrier enhancing approach to the treatment of chronic …See details»
EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding …
Aug 18, 2021 EpiEndo’s lead drug candidate, EP395, aims to be the first on-market oral, non-antibiotic, barrier strengthening and anti-inflammatory macrolide for the treatment of COPD. …See details»
EpiEndo reports Phase 2A results for lead asset, EP395, in COPD
REYKJAVIK, Iceland, April 10, 2024--EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), a clinical-stage biopharmaceutical company developing a new class of oral, barrier-enhancing, …See details»
News & Events | EpiEndo Pharmaceuticals
Maria Bech, CEO of EpiEndo Pharmaceuticals will be presenting at the YAFO Capital Access China Partnering Forum on 24, 25 and 27 September 2024. 15 Aug 2024 EpiEndo to present …See details»
EpiEndo Pharmaceuticals Announces Launch of First-in-Human …
Apr 13, 2021 REYKJAVIK, Iceland--(BUSINESS WIRE)--EpiEndo Pharmaceuticals (www.epiendo.com), a clinical-stage biopharmaceutical company developing novel non …See details»
News & Events | EpiEndo Pharmaceuticals
EpiEndo’s lead drug candidate, EP395, aims to be the first on-market oral, disease modifying, non-antibiotic, barrier strengthening and anti-inflammatory macrolide for COPD. For more …See details»
EpiEndo: Successful Completion of Phase I Study for Lead Asset …
May 18, 2022 EpiEndo Pharmaceuticals: Maria Bech, CEO Email: [email protected] Tel: +354 454 0090 Instinctif Partners (media relations): Rozi Morris / Katie Duffell Email: …See details»
Careers | EpiEndo Pharmaceuticals
Be part of the journey: Careers at EpiEndo. Our culture and values. We're leading the way in developing novel drugs for chronic inflammatory diseases. Our focus on enhancing the …See details»
Therapeutic pipeline | EpiEndo Pharmaceuticals
EpiEndo's pipeline is focused on developing first-in-class, orally-available drugs to target epithelial dysfunction and chronic inflammatory diseases. We are dedicated to improving the lives of …See details»